Hematology, Fibromyalgia, Osteoporosis, Huntington’s Disease, and Cystic Fibrosis are among the therapeutic workshop topics to be presented at the Seventh Annual BIO Investor Forum, taking place October 29-31, 2008 at the Palace Hotel in San Francisco, Calif.
The workshops will address the latest developments in therapies for a wide range of diseases.
Details can be [...]
Filed under: CEO & Investor Conference | 1 Comment »
Today is a very special day for those of us that work in the field of animal biotechnology. Today, the FDA announced the long-awaited draft guidance describing a regulatory framework for governing genetically engineered (GE) animals. In addition, USDA is seeking comment on their coordinated role in the regulatory process.
Some of you will remember that [...]
Filed under: Animal biotechnology, Food and Agriculture | Tagged: FDA, genetically engineered animals, regulatory pathway, USDA | 4 Comments »
Reserve your spot for this national forum for late-stage private and emerging companies. What to expect:
More than 190 late-stage private & emerging public company presentations
Therapeutic panels led by clinical thought leaders
Business roundtables addressing key issues affecting biotech executives
Tech Transfer panel and networking session
Plenary Sessions: Capital Access 201 and The Return to a Thriving Biotech Marketplace [...]
Filed under: BIO Investor Forum | Leave a Comment »
